Table 3 Cost-effectiveness rankings.
Strategy | Net cost | Incremental cost | Effectiveness (QALY) | Incremental effectiveness (QALY) | ICER ($/QALY) |
|---|---|---|---|---|---|
DBS-pc, healthcare sector perspective | |||||
TAU | $79,459 | - | 2.71 | - | - |
DBS | $183,529 | $104,070 | 3.12 | 0.41 | $254,719.81 |
DBS-pc, societal perspective | |||||
TAU | $190,926 | - | 2.71 | - | - |
DBS | $264,039 | $73,113 | 3.12 | 0.41 | $178,949.98 |
DBS-rc, healthcare sector perspective | |||||
TAU | $79,525 | - | 2.71 | - | - |
DBS | $92,549 | $13,025 | 3.12 | 0.41 | $31,878.61 |
DBS-rc, societal perspective | |||||
TAU | $191,011 | - | 2.71 | - | - |
DBS | $173,065 | -$17,946 | 3.12 | 0.41 | -$43,924.23 |
